{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:58:55Z","timestamp":1783573135082,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.yexcr.2021.113007","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T01:40:55Z","timestamp":1641260455000},"page":"113007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II"],"prefix":"10.1016","volume":"412","author":[{"given":"Junjie","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Beers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3951-7061","authenticated-orcid":false,"given":"Juan J.","family":"Marugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1034-0757","authenticated-orcid":false,"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2021.113007_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/003591571701001833","article-title":"A rare disease in two brothers","volume":"10","author":"Hunter","year":"1917","journal-title":"Proc. Roy. Soc. Med."},{"key":"10.1016\/j.yexcr.2021.113007_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00690379","article-title":"Mucopolysaccharidosis type I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain","volume":"39","author":"Dekaban","year":"1977","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.yexcr.2021.113007_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-5876(85)80066-5","article-title":"Pathological and biochemical study in the adenoid of mucopolysaccharidosis II","volume":"10","author":"Fujitani","year":"1985","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.yexcr.2021.113007_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13023-017-0670-9","article-title":"Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics","volume":"12","author":"Aguisanda","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yexcr.2021.113007_bib5","series-title":"Mucopolysaccharidosis Type II","author":"Scarpa","year":"1993"},{"key":"10.1016\/j.yexcr.2021.113007_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.yexcr.2021.113007_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13023-017-0712-3","article-title":"Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS)","volume":"12","author":"Muenzer","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yexcr.2021.113007_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.medcli.2015.06.015","article-title":"Clinical response to long term enzyme replacement treatment in children, adolescent and adult patients with Hunter syndrome","volume":"145","author":"Dalmau Serra","year":"2015","journal-title":"Med. Cl\u00ednica"},{"key":"10.1016\/j.yexcr.2021.113007_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.yexcr.2019.04.021","article-title":"Modelling the neuropathology of lysosomal storage disorders through disease-specific human induced pluripotent stem cells","volume":"380","author":"Kobol\u00e1k","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2021.113007_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.scr.2016.09.033","article-title":"Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutation","volume":"17","author":"Varga","year":"2016","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.yexcr.2021.113007_bib11","doi-asserted-by":"crossref","first-page":"101451","DOI":"10.1016\/j.scr.2019.101451","article-title":"Generation of an induced pluripotent stem cell line (TRNDi008-A) from a Hunter syndrome patient carrying a hemizygous 208insC mutation in the IDS gene","volume":"37","author":"Hong","year":"2019","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.yexcr.2021.113007_bib12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1012763026526","article-title":"A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease)","volume":"24","author":"Voznyi","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.yexcr.2021.113007_bib13","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1093\/hmg\/ddy259","article-title":"Patient iPSC-derived neural stem cells exhibit phenotypes in concordance with the clinical severity of mucopolysaccharidosis I","volume":"27","author":"Swaroop","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2021.113007_bib14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10545-006-0440-7","article-title":"Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis","volume":"29","author":"Sukegawa-Hayasaka","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.yexcr.2021.113007_bib15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1471-4159.1980.tb11220.x","article-title":"Mucopolysaccharidosis types IH, IS, II, and IIIA: glycosaminoglycans and lipids of isolated brain cells and other fractions from autopsied tissues","volume":"34","author":"Constantopoulos","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.yexcr.2021.113007_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00431-011-1606-3","article-title":"The role of enzyme replacement therapy in severe Hunter syndrome-an expert panel consensus","volume":"171","author":"Muenzer","year":"2012","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.yexcr.2021.113007_bib17","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.5966\/sctm.2015-0373","article-title":"Induced pluripotent stem cells for disease modeling and evaluation of therapeutics for niemann-pick disease type A","volume":"5","author":"Long","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.yexcr.2021.113007_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13023-018-0886-3","article-title":"Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease","volume":"13","author":"Vu","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yexcr.2021.113007_bib19","doi-asserted-by":"crossref","first-page":"100549","DOI":"10.1016\/j.ymgmr.2019.100549","article-title":"The nature and impact of neurobehavioral symptoms in neuronopathic Hunter syndrome","volume":"22","author":"Eisengart","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.yexcr.2021.113007_bib20","doi-asserted-by":"crossref","first-page":"15786","DOI":"10.1038\/ncomms15786","article-title":"Insights into Hunter syndrome from the structure of iduronate-2-sulfatase","volume":"8","author":"Demydchuk","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2021.113007_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4939-1154-7_5","article-title":"Chemistry and function of glycosaminoglycans in the nervous system","volume":"9","author":"Schwartz","year":"2014","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.yexcr.2021.113007_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mrgentox.2018.08.013","article-title":"Hunter syndrome: long-term idursulfase treatment does not protect patients against DNA oxidation and cytogenetic damage","volume":"835","author":"Diaz Jacques","year":"2018","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen"},{"key":"10.1016\/j.yexcr.2021.113007_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/gim.2015.36","article-title":"A phase I\/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II,Genetics in medicine","volume":"18","author":"Muenzer","year":"2016","journal-title":"Off. J. Am. College Med. Genetic."},{"key":"10.1016\/j.yexcr.2021.113007_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20082014","article-title":"Targeting brain disease in MPSII: preclinical evaluation of IDS-loaded PLGA nanoparticles","volume":"20","author":"Rigon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2021.113007_bib25","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1089\/hum.2016.184","article-title":"Prevention of neurocognitive deficiency in mucopolysaccharidosis type II mice by central nervous system-directed, AAV9-mediated iduronate sulfatase gene transfer","volume":"28","author":"Laoharawee","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.yexcr.2021.113007_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86696","article-title":"CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)","volume":"1","author":"Motas","year":"2016","journal-title":"JCI insight"},{"key":"10.1016\/j.yexcr.2021.113007_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124299","article-title":"iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases","volume":"4","author":"Lin","year":"2019","journal-title":"JCI insight"},{"key":"10.1016\/j.yexcr.2021.113007_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-030-28471-8_2","article-title":"Utility of induced pluripotent stem cell-derived retinal pigment epithelium for an in vitro model of proliferative vitreoretinopathy","volume":"1186","author":"Greene","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.yexcr.2021.113007_bib29","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1093\/hmg\/ddq420","article-title":"Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy","volume":"19","author":"Polito","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2021.113007_bib30","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/hmg\/ddl038","article-title":"Correction of Hunter syndrome in the MPSII mouse model by AAV2\/8-mediated gene delivery","volume":"15","author":"Cardone","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2021.113007_bib31","first-page":"35","article-title":"Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know","volume":"44","author":"Morrone","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.yexcr.2021.113007_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10545-017-0108-5","article-title":"Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II","volume":"41","author":"Rybova","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.yexcr.2021.113007_bib33","unstructured":"Rostron KA, Lawrence CL,Nile Red Staining of Neutral Lipids in Yeast."},{"key":"10.1016\/j.yexcr.2021.113007_bib34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/10826068.2019.1587624","article-title":"Determining intracellular lipid content of different oleaginous yeasts by one simple and accurate Nile Red fluorescent method","volume":"49","author":"Zhao","year":"2019","journal-title":"Prep. Biochem. Biotechnol."},{"key":"10.1016\/j.yexcr.2021.113007_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jes.2019.05.019","article-title":"1 AS regulates arsenic-induced lipid metabolism through EZH2\/Sirt6\/SREBP-1c pathway","volume":"85","author":"Dong","year":"2019","journal-title":"J. Environ. Sci."},{"key":"10.1016\/j.yexcr.2021.113007_bib36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1083\/jcb.100.3.965","article-title":"Nile red: a selective fluorescent stain for intracellular lipid droplets","volume":"100","author":"Greenspan","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexcr.2021.113007_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-4165(83)90225-8","article-title":"Decreased ganglioside neuraminidase activity in fibroblasts from mucopolysaccharidosis patients Inhibition of the activity in vitro by sulfated glycosaminoglycans and other compounds","volume":"761","author":"Baumk\u00f6tter","year":"1983","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.yexcr.2021.113007_bib38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.yexcr.2021.113007_bib39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1126\/science.181.4097.352","article-title":"Mucopolysaccharidosis: secondarily induced abnormal distribution of lysosomal isoenzymes","volume":"181","author":"Kint","year":"1973","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.yexcr.2021.113007_bib40","volume":"vol. 5","author":"Lajtha","year":"1982"},{"key":"10.1016\/j.yexcr.2021.113007_bib41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cne.20355","article-title":"Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders","volume":"480","author":"McGlynn","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.yexcr.2021.113007_bib42","doi-asserted-by":"crossref","first-page":"39349","DOI":"10.1074\/jbc.M112.357707","article-title":"delta-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders","volume":"287","author":"Xu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2021.113007_bib43","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/1087057114537378","article-title":"Niemann-Pick disease type C: induced pluripotent stem cell-derived neuronal cells for modeling neural disease and evaluating drug efficacy","volume":"19","author":"Yu","year":"2014","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.yexcr.2021.113007_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02652048.2017.1409819","article-title":"Cyclodextrin encapsulation of daidzein and genistein by grinding: implication on the glycosaminoglycan accumulation in mucopolysaccharidosis type II and III fibroblasts","volume":"35","author":"Fumic","year":"2018","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.yexcr.2021.113007_bib45","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2017.1329081","article-title":"Methyl-beta-cyclodextrin restores impaired autophagy flux in Niemann-Pick C1-deficient cells through activation of AMPK","volume":"13","author":"Dai","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.yexcr.2021.113007_bib46","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1093\/hmg\/ddv153","article-title":"BCM-95 and (2-hydroxypropyl)-beta-cyclodextrin reverse autophagy dysfunction and deplete stored lipids in Sap C-deficient fibroblasts","volume":"24","author":"Tatti","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2021.113007_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235829","article-title":"Autophagy in the central nervous system and effects of chloroquine in mucopolysaccharidosis type II mice","volume":"20","author":"Maeda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2021.113007_bib48","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/1087057114537378","article-title":"Niemann-Pick disease type C: induced pluripotent stem cell-derived neuronal cells for modeling neural disease and evaluating drug efficacy","volume":"19","author":"Yu","year":"2014","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.yexcr.2021.113007_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2021.113007_bib50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10545-012-9583-x","article-title":"Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability","volume":"36","author":"Pontikis","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.yexcr.2021.113007_bib51","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/NEN.0b013e318286587f","article-title":"Electrodiagnostic testing and histopathologic changes confirm peripheral nervous system myelin abnormalities in the feline model of niemann-pick disease type C","volume":"72","author":"Bagel","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.yexcr.2021.113007_bib52","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00431-018-3219-6","article-title":"Pulmonary involvement in Niemann-Pick C type 1","volume":"177","author":"Staretz-Chacham","year":"2018","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.yexcr.2021.113007_bib53","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0022-3476(05)81695-6","article-title":"Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease","volume":"123","author":"Kelly","year":"1993","journal-title":"J. Pediatr."},{"key":"10.1016\/j.yexcr.2021.113007_bib54","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1017\/S1751731113001250","article-title":"Methyl-\u03b2-cyclodextrin alters adipokine gene expression and glucose metabolism in swine adipose tissue","volume":"7","author":"Ramsay","year":"2013","journal-title":"Animal"}],"updated-by":[{"DOI":"10.1016\/j.yexcr.2023.113808","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000}}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721005632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721005632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T08:36:35Z","timestamp":1643445395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482721005632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0014482721005632"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.113007","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.yexcr.2023.113808","asserted-by":"object"}]},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.113007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113007"}}